| Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy M Ravanelli, D Farina, M Morassi, E Roca, G Cavalleri, G Tassi, R Maroldi European radiology 23, 3450-3455, 2013 | 136 | 2013 |
| Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and outcomes with nivolumab in pretreated non-small cell lung cancer (NSCLC): a large retrospective … A Russo, M Russano, T Franchina, MR Migliorino, G Aprile, G Mansueto, ... Advances in therapy 37, 1145-1155, 2020 | 134 | 2020 |
| Management of endocrine disease: risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects G Mazziotti, AM Formenti, S Frara, E Roca, P Mortini, A Berruti, A Giustina European journal of endocrinology 177 (5), R231-R248, 2017 | 83 | 2017 |
| 106th Congress of the Italian Society of Otorhinolaryngology Head and Neck Surgery Official report: Surgery of the lateral skull base: a 50-year endeavour E Zanoletti, A Mazzoni, A Martini, RV Abbritti, R Albertini, E Alexandre, ... Acta Otorhinolaryngologica Italica 39 (3 Suppl 1), S1, 2019 | 80 | 2019 |
| Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis E Roca, C Gurizzan, V Amoroso, W Vermi, V Ferrari, A Berruti Cancer Treatment Reviews 59, 117-122, 2017 | 76 | 2017 |
| Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations F Passiglia, F Cappuzzo, O Alabiso, AC Bettini, P Bidoli, R Chiari, ... British journal of cancer 120 (1), 57-62, 2019 | 75 | 2019 |
| Malignant pleural mesothelioma: from the bench to the bedside P Astoul, E Roca, F Galateau-Salle, A Scherpereel Respiration 83 (6), 481-493, 2012 | 62 | 2012 |
| Testosterone levels and prostate cancer prognosis: systematic review and meta-analysis M Claps, F Petrelli, O Caffo, V Amoroso, E Roca, A Mosca, F Maines, ... Clinical genitourinary cancer 16 (3), 165-175. e2, 2018 | 51 | 2018 |
| Clinical significance of skin toxicity due to EGFR-targeted therapies M Giovannini, V Gregorc, C Belli, E Roca, C Lazzari, MG Vigano, ... Journal of oncology 2009, 2009 | 50 | 2009 |
| Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world … L Cantini, G Mentrasti, GL Russo, D Signorelli, G Pasello, E Rijavec, ... ESMO open 7 (2), 100406, 2022 | 48 | 2022 |
| CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer GM Agazzi, M Ravanelli, E Roca, D Medicina, P Balzarini, C Pessina, ... La radiologia medica 126, 786-794, 2021 | 45 | 2021 |
| Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing … M Ravanelli, GM Agazzi, E Tononcelli, E Roca, P Cabassa, G Baiocchi, ... La radiologia medica 124, 877-886, 2019 | 45 | 2019 |
| Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) M Imbimbo, M Ottaviano, M Vitali, A Fabbri, G Leuzzi, M Fiore, ... Cancer Treatment Reviews 71, 76-87, 2018 | 45 | 2018 |
| Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case E Roca, M Pozzari, W Vermi, V Tovazzi, A Baggi, V Amoroso, D Nonnis, ... Lung Cancer 127, 12-18, 2019 | 44 | 2019 |
| Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options S Puglisi, P Perotti, D Cosentini, E Roca, V Basile, A Berruti, M Terzolo Expert Review of Anticancer Therapy 18 (11), 1125-1133, 2018 | 41 | 2018 |
| Osimertinib in EGFR Mutation-Positive Advanced NSCLC. JC Soria, SS Ramalingam The New England journal of medicine 378 (13), 1262-1263, 2018 | 38 | 2018 |
| Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer E Roca, A Berruti, S Sbiera, I Rapa, E Oneda, P Sperone, CL Ronchi, ... Endocrine-related cancer 24 (7), 319-327, 2017 | 38 | 2017 |
| Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: a cross-sectional study R Pedersini, S Monteverdi, G Mazziotti, V Amoroso, E Roca, F Maffezzoni, ... Bone 97, 147-152, 2017 | 38 | 2017 |
| Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions E Roca, R Lacroix, C Judicone, S Laroumagne, S Robert, S Cointe, ... Oncotarget 7 (3), 3357, 2016 | 37 | 2016 |
| Tallimustine in advanced previously untreated colorectal cancer, a phase II study CJA Punt, Y Humblet, E Roca, LY Dirix, R Wainstein, A Polli, I Corradino British journal of cancer 73 (6), 803-804, 1996 | 35 | 1996 |
